Avenue Therapeutics (ATXI) Institutional Ownership $0.54 -0.03 (-5.26%) As of 10:29 AM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Avenue Therapeutics (NASDAQ:ATXI)CurrentInstitutional OwnershipPercentage17.34%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$109.57KNumber ofInstitutional Sellers(last 12 months)0 Get ATXI Insider Trade Alerts Want to know when executives and insiders are buying or selling Avenue Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ATXI Institutional Buying and Selling by Quarter Avenue Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025 Boothbay Fund Management LLC41,089$82K0.0%N/A2.004% 10/18/2024 Moss Adams Wealth Advisors LLC11,000$27K0.0%N/A1.169% 8/15/2024 Armistice Capital LLC75,000$262K0.0%N/A7.970% 1/28/2022National Asset Management Inc.71,338$65K0.0%-20.1%0.376% 11/16/2021National Asset Management Inc.89,237$133K0.0%-29.2%0.531% 10/19/2021Kestra Advisory Services LLC22,500$34K0.0%N/A0.134% 9/17/2021 Virtu Financial LLC26,373$66K0.0%N/A0.157% 9/3/2021Parametric Portfolio Associates LLC10,554$26K0.0%-59.2%0.063% 8/16/2021 Occudo Quantitative Strategies LP14,398$36K0.0%N/A0.086% 8/13/2021 Renaissance Technologies LLC78,314$197K0.0%N/A0.468% 8/13/2021 Northern Trust Corp13,767$35K0.0%-82.1%0.082% 8/13/2021 Geode Capital Management LLC79,556$199K0.0%-40.0%0.475% 8/13/2021 Vanguard Group Inc.449,982$1.13M0.0%-35.5%2.687% 8/12/2021 XTX Topco Ltd10,864$27K0.0%N/A0.065% 8/12/2021Advisory Services Network LLC35,121$88K0.0%N/A0.210% 8/12/2021Ergoteles LLC30,400$76K0.0%N/A0.182% 8/10/2021National Asset Management Inc.126,037$317K0.0%-26.1%0.753% 5/19/2021 Squarepoint Ops LLC11,668$71K0.0%N/A0.070% 5/17/2021 Goldman Sachs Group Inc.17,319$105K0.0%N/A0.103% (Data available from 1/1/2016 forward) ATXI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ATXI shares? During the previous two years, the following institutional investors and hedge funds held shares of Avenue Therapeutics shares: Armistice Capital LLC ($262K), and Boothbay Fund Management LLC ($82K), Moss Adams Wealth Advisors LLC ($27K).Learn more on Avenue Therapeutics' institutional investors. What percentage of Avenue Therapeutics' stock is owned by institutional investors? 17.34% of Avenue Therapeutics' stock is owned by institutional investors. Learn more on ATXI's institutional investor holdings. Which institutional investors have been buying Avenue Therapeutics' stock? The following institutional investors have purchased Avenue Therapeutics' stock in the last 24 months: Armistice Capital LLC ($75K), Boothbay Fund Management LLC ($41.09K), and Moss Adams Wealth Advisors LLC ($11K). How much institutional buying is happening at Avenue Therapeutics? Institutional investors have bought a total of 52,089 shares in the last 24 months. This purchase volume represents approximately $109.57K in transactions. Related Companies GENPREX Major Shareholders Alzamend Neuro Major Shareholders Artelo Biosciences Major Shareholders IN8bio Major Shareholders Brainstorm Cell Therapeutics Major Shareholders Mainz Biomed Major Shareholders Sunshine Biopharma Major Shareholders Apollomics Major Shareholders Cardio Diagnostics Major Shareholders Nuvilex Major Shareholders This page (NASDAQ:ATXI) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avenue Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avenue Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access